2021
517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial
Branch-Elliman W, Ferguson R, Doros G, Woods P, Leatherman S, Strymish J, Datta R, Goswami R, Jankowich M, Shah N, Taylor T, Page S, Schiller S, Shannon C, Hau C, Flynn M, Holmberg E, Visnaw K, Dhond R, Brophy M, Monach P. 517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial. Open Forum Infectious Diseases 2021, 8: 360-360. PMCID: PMC8690689, DOI: 10.1093/ofid/ofab466.716.Peer-Reviewed Original ResearchSubcutaneous sarilumabStandard careMechanical ventilationLearning healthcare systemClinical trialsSevere COVID-19 diseaseCOVID-19Rate of intubationSevere COVID-19Trial of patientsCare clinical trialsIL-6 inhibitionTreatment of patientsNumber of patientsStandard of careHealthcare systemEvidence of benefitCOVID-19 diseaseData monitoring committeeA PragmaticPrimary endpointChart reviewHospitalized patientsPrimary outcomeSupplemental oxygenSurveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness
Datta R, Barrett A, Burk M, Salone C, Au A, Cunningham F, Fisher A, Dembry LM, Akgün KM. Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness. Infection Control And Hospital Epidemiology 2021, 43: 1488-1491. PMID: 33985598, PMCID: PMC8160489, DOI: 10.1017/ice.2021.227.Peer-Reviewed Original Research
2019
Knowledge and Practices of Physicians and Nurses Related to Urine Cultures in Catheterized Patients: An Assessment of Adherence to IDSA Guidelines
Advani S, Gao C, Datta R, Sann L, Smith C, Leapman MS, Hittelman A, Sabetta J, Dembry LM, Martinello RA, Juthani-Mehta M. Knowledge and Practices of Physicians and Nurses Related to Urine Cultures in Catheterized Patients: An Assessment of Adherence to IDSA Guidelines. Open Forum Infectious Diseases 2019, 6: ofz305. PMID: 31375836, PMCID: PMC6677670, DOI: 10.1093/ofid/ofz305.Peer-Reviewed Original ResearchCatheter-associated urinary tract infectionsClostridioides difficile infectionUrine cultureChart reviewPractice patternsInitiation of antimicrobialsUrine culture ordersPositive urine cultureInfectious Diseases SocietyUrinary tract infectionAcademic health care systemAbsence of symptomsDrug adverse eventsAssessment of adherencePractices of physiciansHealth care systemOdor of urineIDSA guidelinesCatheterized patientsAdverse eventsDiseases SocietyTract infectionsDifficile infectionUrinary catheterResponse rate
2013
Discord among Performance Measures for Central Line—Associated Bloodstream Infection
Tehrani DM, Russell D, Brown J, Boynton-Delahanty K, Quan K, Gibbs L, Braddock G, Zaroda T, Koopman M, Thompson D, Nichols A, Cui E, Liu C, Cohen S, Rubin Z, Pegues D, Torriani F, Datta R, Huang SS. Discord among Performance Measures for Central Line—Associated Bloodstream Infection. Infection Control And Hospital Epidemiology 2013, 34: 176-183. PMID: 23295564, DOI: 10.1086/669090.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAdolescentAdultAgedAged, 80 and overBacteremiaCaliforniaCatheter-Related InfectionsCenters for Medicare and Medicaid Services, U.S.Clinical CodingCross InfectionFemaleHumansInsurance Claim ReviewMaleMandatory ProgramsMedical AuditMiddle AgedRetrospective StudiesUnited StatesYoung AdultConceptsCentral line-associated bloodstream infectionsChart reviewConsecutive patientsBloodstream infectionsNHSN criteriaClaims codesCommon reasonNational Healthcare Safety Network criteriaCentral Line–Associated Bloodstream InfectionsMulticenter retrospective cohort studyLine–Associated Bloodstream InfectionsLine-associated bloodstream infectionsRetrospective cohort studyMedical record reviewCLABSI eventsCLABSI reportingCohort studyRecord reviewPrevention criteriaClaims dataNetwork criteriaPhysician documentationClaims cohortPatientsDisease control